WaveFront Dynamics (WaveDyn) develops an ophthalmic measurement device that captures dynamic wavefront measurements of the eye over time rather than single snapshots. The company’s core product is a proprietary dynamic wavefront measurement system intended to improve diagnosis and guide treatment for complex visual dysfunction. WaveDyn plans to leverage these dynamic measurements to create ophthalmic treatment solutions and advance clinical options for patients. The company will use the new funding to continue device development and to conduct subsequent clinical studies. WaveDyn was founded in 2019 and is based in Albuquerque, N.M.; Dan Neal, PhD, is founder and CEO. The company positions its technology as having potential to improve visual performance for large patient populations.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2020